This document summarizes a medication adherence platform called Medisafe. It discusses how Medisafe addresses the major causes of non-adherence through personalized medication management. The document also provides data on medication non-adherence costs and statistics, an overview of Medisafe's features and user growth, clinical studies showing improved adherence, and strategies for expanding the platform to involve providers and payers. It analyzes the competitive landscape and outlines how Medisafe differentiates itself as the market leader in medication management.
HXR 2016: The Health IoT: Remote Care and Mobile Solutions -Manu Varma, PhilipsHxRefactored
The digital transformation of healthcare is collecting millions of data points from connected devices that monitor patients. Chronic conditions are increasing globally and healthcare spending is rising unsustainably. Digital technologies enable moving from reactive to proactive health by providing a longitudinal personalized overview of patients through monitoring, informatics and connected care. Philips partners with healthcare organizations to implement telehealth programs that have led to faster discharge rates from hospitals and ICUs, as well as significant cost savings through reduced readmissions. Digital technologies are transforming healthcare delivery from reactive to proactive models through connected health across settings.
Joshua Newman discusses how healthcare organizations can provide whole patient care through the use of customer relationship management (CRM) technology and telemedicine. CRM allows for a complete view of patient information in real-time, seamless care coordination, and continuous digital engagement. This is exemplified by 180 Health Partners, who uses a CRM platform to coordinate home visits and engage expecting mothers battling substance abuse both during and after pregnancy. CRM brings together data, people, and builds personalized journeys of awareness, diagnosis, treatment and more to provide a continuum of engagement anywhere.
SpaKinect is a telehealth company that provides good faith evaluations for medical spas prior to aesthetic treatments, as required by medical boards. They create an on-demand network of practitioners with expertise in aesthetic medicine to evaluate patients virtually. This allows for cost-effective and timely evaluations that comply with standards of care, improving wait times over in-person visits. SpaKinect utilizes technology like AI and analytics to constantly improve their telehealth program and ensure providers have up-to-date information.
Telehealth Secrets 2019: Health Experience 2030 and beyond - Unmesh Srivastan...VSee
This document discusses a vision for reinvented healthcare experiences by 2030. It notes that consumer expectations are increasing in other industries around convenience and personalization, but healthcare has not kept up. A modernized healthcare system would integrate telehealth, natural language processing, machine learning and a marketplace approach to provide more transparent, accessible and personalized care centered around the consumer. This could track patients' health continuously, escalate issues appropriately, and deliver tailored healthcare packages and rewards programs through a single integrated experience resembling platforms like Amazon. The goal is improved outcomes through faster, more convenient care that empowers consumers to make informed choices about their healthcare needs.
HXR 2016: Tracking the Body: Devices, Consumer Genomics, and Sensors- Aymen E...HxRefactored
The document discusses Massive Bio, Inc. (MBI), a platform that aims to overcome barriers to precision cancer care by providing a digital analytics platform, virtual tumor board, live support, and other services. It outlines challenges currently facing cancer patients, oncologists, insurance companies, and academic centers due to siloed information and lack of infrastructure and support. The MBI platform integrates patient data, guidelines, clinical trials, and partners to provide testing and treatment recommendations through a virtual tumor board, as well as primary oncologist support, reimbursement guidance, and outcomes comparisons. A demo of the GUI is shown and value propositions for stakeholders over phases 1 and 2 are outlined. The team behind MBI is also
Artificial Intelligence—Infinite Possibilities: Adam Hanina, AICure (Digital ...Jill Gilbert
How are Pharma and health systems using artificial intelligence to improve outcomes and lower costs? AiCure will present a live demonstration of how their AI platform will tackle a major challenge taxing the healthcare system — medication adherence. You’ll see how their technology will not only positively impact clinical trial success rates and improve patient behavior, but will also help reduce the costs attributed to our nationwide lack of medication compliance.
Apply loyalty science to incent, change and increase appropriate health and health benefit utilization behaviors that will improve health outcomes and reduce costs.
On November 5th, J.D. Power will be publishing the first Telehealth Satisfaction Study. Some key findings include:
- Only 9.6% of health consumers have used telehealth in the past 12 months.
- Top barriers for non-users were being unaware it was an option, wanting to see a provider in person, and concern over quality of care.
- Factors like cost, provider access to records, and service security would increase likelihood of future telehealth use.
- 72% of non-users would try telehealth if their cost was less than a doctor's office visit.
HXR 2016: Free the Data Access & Integration -Aashima Gupta, ApigeeHxRefactored
Utilizing the power of data can empower patients and arm developers in the creation of new tools and platforms. Whether it’s authenticating data, downloading it via BlueButton, or connecting data with other applications using BlueButton on FHIR, increased data accessibility is a win for everyone. Presenters will give an overview of the opportunities and challenges that exist today and share the newest technologies and initiatives that are overcoming them.
The New Age of Healthcare Ecosystems: Infographic (1)IBM in Healthcare
Learn how ecosystems will change the nature of business activities, expand capabilities and enable experiences in healthcare and life sciences beyond anything possible today.
To know more, visit: ibm.biz/healthecos
HXR 2016: Data Insights: Mining, Modeling, and Visualizations- Farid JamshidianHxRefactored
Data is useless if it fails to inform, which is precisely what data experts are furiously working on: turning raw informatics into meaningful narratives that begin to shift our standards. From the individual to the population level, data is leading both policy and better decision making in the clinical sphere.
Strategies by which Personal Health Record Vendors Increase Market ShareNS_Slideshare
Highlights of research:
*Usage more than doubled from 2.7% in 2008 to 7% in 2009. However, current users are not those who can use it the most (elderly, chronically ill, low-income)
*Top barriers to use: privacy concerns, lack of physician support of phr use, patients not compelled to use phr (associated solutions offered)
*Conclusions: Though many varying opinions, very little data to support clear concensus of direction of PHR industry. However, companies such as Google and Microsoft are continuing with PHR product.
*Recommendations: PHR vendors should parter with fitness/medical device products and charge interface fee, Generate revenue through advertisements on home page of PHR record, Partner with insurance companies, hospitals, physician offices, employers as preferred PHR vendor.
Please review poster for more details including differences between Google and MS Health Vault, a fee-based PHR model and risks.
The document discusses non-communicable diseases (NCDs) as a major health problem globally and in Latin America and the Caribbean. It notes that NCDs account for 78% of deaths in the region and will cost an estimated $47 trillion worldwide by 2030. The document also discusses issues with existing electronic health record (EHR) systems and the need for a better monitoring system for patients and doctors. It then introduces a mobile app solution that would allow patients to manage medications, record symptoms, and communicate with doctors and caregivers to improve post-discharge healthcare and reduce NCD healthcare costs and burden on systems.
1) The document discusses mHealth apps and innovations. It highlights that apps targeting diabetics have the biggest market potential.
2) It summarizes two reports on the diabetes app market and the mHealth app developer economy. The reports analyze market trends, top publishers, and forecasts.
3) The presentation discusses how mHealth can move beyond adherence tracking to deliver true value across the spectrum of care from patients to clinicians. It provides examples of apps that have successfully driven health outcomes.
This document discusses the potential for a mental health app system to help the millions of Americans suffering from mental illness. It notes that nearly 25 million Americans experience serious psychological distress each year, but only a portion receive treatment. It then outlines features of a proposed mental health app system that could increase self-monitoring, reduce emergency room visits and costs, and enable more effective early treatment through data collection. The app system would provide a support network and reporting tools to help and connect patients, caregivers, and clinicians. It argues that such a system could improve health outcomes and lower healthcare costs if designed based on evidence-based practices and efficacy metrics.
Government data shows rising OOP spending for consumers, but excludes some types of health-related items and services that can add significantly to the total amount and consumer share of spending. This infographic exposes these “hidden costs” that account for almost one-fifth of total health care spending.
For more information, visit
Even though EHRs have replaced paper health records aiming to make data management more convenient, managing health records is still an apprehension for patients. With the introduction of BlueButton 2.0, patients will have access to 4 years of their health record. This gives the patients more confidence in their health care and make data more comprehensive and easily accessible. By facilitating access to patient health history, it has the potential to drive down Medicare spending and improve health outcomes.
Infographic Consumerization and Mobility in Healthcare 2016Phil Vickman
Consumerization and mobility in healthcare are top change drivers influencing providers, payers, and consumers. Medical professionals are increasingly using mobile devices and technologies to facilitate patient care, coordinate with patients, and expedite decision making. A growing number of consumers also utilize health and wellness apps on their mobile devices to communicate with doctors, access health records and treatment information, and manage their care.
HxRefactored 2015: MediSafe "Cloud-Synced Medication Management for Patients ...HxRefactored
MediSafe introduces their medication
management solution cloud-synced mobile app designed to help people integrate healthier behaviour into their daily lives.
Medication Adherence Trends in North CarolinaRobert Nauman
This document summarizes key findings from the 2010 North Carolina Behavioral Risk Factor Surveillance System (BRFSS) survey regarding prescription medication adherence. The BRFSS is an annual phone survey of state residents aged 18 and older on health behaviors and risks. In 2010, the NC survey included a module on prescription adherence. It found that 17% of respondents statewide reported not filling a prescription in the past year, most commonly due to concerns about side effects or believing the medication would not help. Rates varied by demographic factors. The report identifies groups most at risk of non-adherence and next steps.
This document discusses medication adherence and proposes a mHealth approach using automated medication reminders triggered from pharmacy dispensing data to improve adherence. Key points:
- Medication non-adherence is a major healthcare problem, with 50% of chronic patients not following treatment plans. This costs $100-290 billion annually in the US.
- An automated reminder system would use dispensing data like medication name, dose, frequency from pharmacies to set reminders in an app to prompt users when to take medications and track adherence.
- This approach could improve medication adherence rates especially as more use smartphones and wearables, helping address the large costs and health impacts of non-adherence.
160317 presentatie memo patch® innovation in medication adherence (bram van ...SMBBV
Presentation by Bram van Dijck, CEO TheraSolve on MemoPatch, an innovation in medication adherence. Presented during Science Meets Business meeting from SMB Life Sciences during Health Valley Event 2016.
The document discusses medication non-adherence and strategies for improving adherence and ensuring safe hospital discharges. It notes that 50% of prescribed medications are not taken correctly and identifies barriers to adherence like cost, side effects, and health literacy. It introduces the Case Management Adherence Guidelines (CMAG) which assess patient knowledge, motivation, and skills to improve adherence using tools like health literacy tests. CMAG provides an algorithm to improve understanding and motivate patients to take medications as prescribed. The document emphasizes the importance of educating patients before discharge to maintain treatment and ensure a safe transition to outpatient care.
This document discusses patient medication adherence. It defines adherence as taking medication as recommended by a healthcare provider. Non-adherence can be unintentional due to complex regimens or intentional if a patient stops medication. The World Health Organization identified 5 dimensions that influence adherence: social/economic factors, healthcare system factors, condition-related factors, therapy-related factors, and patient-related factors. Methods for measuring adherence include medication monitors, patient self-reports, pill counts, pharmacy records, and the Morisky Medication Adherence Scale. Pharmacists can improve adherence through education, simplifying regimens, identifying barriers, and reminding patients.
Increasing Burden of NCD in Malaysia: Challenges in resource allocationFeisul Mustapha
This document discusses the increasing burden of non-communicable diseases (NCDs) in Malaysia and the challenges in allocating resources. It notes that NCDs such as heart disease, diabetes, cancers and chronic lung disease account for over 75% of deaths in Malaysia and result in high economic costs. Risk factors like tobacco use, unhealthy diets, physical inactivity and alcohol consumption contribute significantly to the disease burden. While population-based interventions targeting these risk factors can help reduce NCD rates cost-effectively, the growing number of people with NCDs or at high risk of NCDs poses challenges for resource allocation and achieving universal healthcare coverage in Malaysia.
The company has effectively implemented various HR techniques at its plant like 5S, Kaizens, SQC, TQM and Poka-Yoke. Workers are aware of these concepts and their implementation has reduced wastage. HACCP standards are followed for food safety. Wastage is minimized through techniques like reprocessing undersized/overbaked biscuits and sending total wastage to poultry farms. Workers surveyed showed positive response to the techniques adopted by the plant and suggested some further focus areas for improvement.
Five Keys To Success In The New Patient EconomyRAPP
In the new Patient Economy, commonly used approaches are no longer effective for engaging patients – and more importantly, for delivering better patient outcomes.
RAPP NY hosted a webinar in June of 2016 that dives into five tips and tricks for optimizing success in the new patient economy. Learn tips and strategies for transforming your patient engagement model, along with the following:
• Why successful outcomes, not prescriptions, are the new measure of success
• What patients really want in the new Patient Economy
• Proven strategies for delivering superior patient experiences and outcomes
• Practical steps you can take to get started on your transformation
- The document discusses the requirements and incentives for physicians to achieve Meaningful Use of electronic health records as part of the government's stimulus program.
- Physicians must meet objectives in three stages involving electronic prescribing, clinical quality reporting, and advanced clinical processes to receive incentive payments of up to $44,000 from Medicare or $63,750 from Medi-Cal.
- Achieving Meaningful Use requires efforts from physicians, medical assistants, and office staff according to defined roles and responsibilities for data capture, review, and reporting.
Is mHealth Prescribing: Dead or Thriving?AppScript
App rating is happening everywhere in the ecosystem, but without putting apps in practice, evaluating the prescribing data and patient feedback, we only have half the story. Learn about the prescribing data, rating and scoring methodologies and the evidence of the growing promise of mobile health curation, discovery and distribution.
The document discusses the medical home model as a disruptive innovation for primary care. It proposes paying primary care physicians for coordinating patient care and managing health outcomes and costs through a medical home model. This shifts care from a specialist-focused model to a simpler, rules-based primary care model. The medical home aims to provide integrated, whole-person care through teams led by primary care physicians. It also discusses pilots of medical homes, challenges, and the potential for cost savings through reduced errors, care gaps, and procedures.
The document discusses point-of-care patient recruitment programs that can help pharmaceutical companies address challenges in clinical trial recruitment. It notes that physicians are the most trusted source of healthcare information and that over 50% of clinical trial participants join at their doctor's suggestion. SMI offers programs that create physician endorsement for clinical trials by providing branded materials for exam rooms and waiting areas, which has led to increased patient interest and enrollment in various case studies described.
Healthcare is undergoing a transformation. Consumers want to make informed choices and take control of their lives, and pharma companies must be ready to meet their needs. This means building a new healthcare ecosystem that places the patient at its center, with the “person” fully engaged in his or her own healthcare. But with this move to person-centric healthcare, payers and providers are no longer the main decision makers.
So what does this mean for today’s marketers?
In this exclusive Social On Us webinar we discuss:
- Where marketing is failing to address healthcare concerns
- How “big data” is a change-driver for a new healthcare ecosystem
- New opportunities for predictive and preventative medical intervention
- Impact of digital healthcare on patient privacy
Patient Engagement is growing in importance as consumer expectations of healthcare providers change and as portals and other technologies improve. Early studies show affects on outcomes for patient engagement technologies
The Complete Guide to Wellness Software DevelopmentMentorMate
Healthcare. It’s just one word, but it feels like over a hundred problems and potential solutions spun up like a spider web — benefits, cost savings and improvements are stuck together without being truly connected.
The client, a dominant market leader in oncology, wanted to optimize their sales and marketing strategies to increase market share and prepare for new competitors. A case study was conducted using qualitative interviews and quantitative surveys of oncologists in France and Germany. The study found the client's product was the 2nd most prescribed but had an opportunity to grow in certain cancer types. It was recommended the client focus messaging on protocols that trigger prescriptions of their single injection product to increase market share based on convenience and cost savings versus competitors.
1. The document describes a personalized patient media platform that aims to improve medication adherence through increased communication between patients and physicians. 2. The program involves patients enrolling and taking surveys about their treatment experience, then receiving individualized reports to track their progress and share with their doctor. 3. Evaluation found the program improved adherence by 17-27% on average, built physician confidence, and both physicians and patients felt it enhanced their communication.
1. The document describes a personalized patient media platform that aims to improve medication adherence through increased communication between patients and physicians. 2. The program involves patients enrolling and taking surveys about their treatment experience, then receiving individualized reports to track their progress and share with their doctor. 3. Evaluation found the program improved adherence by 17-27% on average, built physician confidence, and both physicians and patients felt it enhanced their communication.
Mobile companion apps can be used to extend the patient-provider relationship beyond traditional in-person interactions. However, past health apps have often failed because they were disconnected from existing health records and clinical workflows. Effective companion apps would need to integrate with electronic health record systems used by providers and address how doctors would use the apps as part of their existing practices. Developing companion apps can help improve patient engagement, satisfaction, and trust in providers by providing information to patients before and after visits and strengthening the personal connection in healthcare.
This document discusses using analytics to optimize medication adherence interventions. It begins by introducing GNS Healthcare and their Meaningful Adherence solution, which uses predictive modeling to precisely match individuals to specific adherence interventions that will maximize the return on investment. It then provides examples showing how value-based selection identifies more individuals who could benefit from interventions compared to rules-based selection based solely on medication possession ratio. The document concludes by outlining GNS's approach and analytics platform for planning, implementing, and continuously optimizing population health management programs and adherence interventions.
A survey was conducted of patients, physicians, payers, and pharmaceutical companies on the current use and potential of patient portals in electronic health records (EHRs) to improve health outcomes. The survey found that while only 18% of patients currently use patient portals, a greater percentage are interested in features like tracking health progress and accessing medical records and educational materials. Physicians see value in portals for care management but many do not currently offer them, and payers and pharma companies have limited familiarity with or engagement in portals. In conclusion, patient portals are underused given patient interest, and greater coordination is needed across stakeholders to realize their benefits.
Pharmaceutical Digital Marketing ProjectsZdravko Mauko
This document discusses how pharmaceutical companies can transform pharmacovigilance and adherence tools into customer experience management. It notes that the age of blockbuster drugs is over and new approaches are needed using big data, mobile apps, and a focus on preventative medicine and patient empowerment. Poor medication adherence is a major issue, compromising the real-world benefits of drugs, but new digital technologies now allow companies to better support patients and improve outcomes. Case studies show how mobile apps and remote coaching can significantly increase adherence and patient satisfaction for conditions like asthma and eczema.
Revenue at Risk: Understanding Financial Impacts of Quality ReportingBill Presley
Jodi Frei, Northwestern Medical Center Vermont, and I co-presented at the MUSE Executive Institute on Revenue at Risk: Understanding Financial Impacts of Quality Reporting. The Executive Institute featured many amazing CXO's discussing the changing landscape of revenue cycle management and how finance, quality, and IT departments are converging on revenue cycle.
Though pay for performance is the common theme, the logistics of programs including Value Based Purchasing (VBP), Inpatient Quality Reporting (IQR), Hospital Acquired Condition (HAC) Reduction Program, Readmission Reduction, MACRA, MIPS and APMs, are very different. In this session, the specifics of each Quality Program including reporting requirements, scoring methodologies, and associated incentives and penalties will be covered. In addition, tools to track performance and quantify financial risk will be shared.
Reimbursement in this era of health care reform is challenging. We all seek success under this new normal in health care. Optimizing revenue capture in a quality reimbursement model requires acquisition of new knowledge and the use of new tools and strategies. Join us in the conversation; share your strategies; learn from others.
- Surgical site infections (SSIs) develop in 2-5% of surgical patients annually in the US, accounting for 14-16% of all hospital-acquired infections and 3% of surgical mortality. They increase costs by $29,000 per patient on average.
- A survey of 103 healthcare professionals found that most facilities have protocols for preoperative skin cleansing, though compliance levels vary. The majority use chlorhexidine gluconate (CHG) products and require two or more applications.
- Improving patient education and compliance was cited as the most significant obstacle to reducing SSIs. Less than 10% of facilities used digital reminders or referred patients to informational websites.
Ομιλία – Παρουσίαση: Raymond Anderson, President Commonwealth Pharmaceutical Association and Member of the Pharmacovigilance Risk Assessment Committee (PRAC) at EMA
«Best Practices to inform citizens on Self-medication»
This study evaluated the perceptions of general practitioners (GPs) and community pharmacists (CPs) in Penang, Malaysia towards consumer reporting of Adverse Drug Reactions (ADRs). A survey was sent to 192 CPs and 400 GPs, with a response rate of 18%. The majority of respondents agreed that consumer reporting would add benefits to existing pharmacovigilance programs and increase knowledge of ADRs. However, many respondents doubted consumers' ability to write valid reports similar to healthcare professionals and believed more consumer education was needed. The study concluded that while respondents recognized the importance of consumer reporting, barriers around consumers' reporting abilities need to be addressed through increased education by media and non-governmental organizations.
Leveraging Mobile Apps and Digital Therapeutics to Improve Behavioral HealthSpectrum Health System
In this presentation, the top apps and digital therapeutics for behavioral health, with a focus on stress, depression, and anxiety, will be reviewed including a summary of program offerings and patient outcomes. Strategies for embedding digital health programs as complements to traditional behavioral health treatment will be discussed. The design and results of a recent implementation of mobile app prescriptions as part of standard care in 12 clinical areas with 70 plus prescribing providers will be described. Engagement and acceptability data from patients and providers will be shared. Strategies for developing standard work and governance for this new category of behavioral health treatment will be offered. Discussion will center on how mobile health represents a high value, low-cost care transformation for the future of health care.
Beyond the Functional: Let's Get Personal Jon Michaeli
This document discusses Medisafe, a cloud-synced medication management app for patients and caregivers. It addresses major causes of non-adherence like forgetfulness and lack of support. Medisafe has grown to over 1.6 million users since launching in 2012. It provides reminders, education, and feedback to help users take medications correctly. The company aims to expand the platform to include wearables and rekindle relationships between patients and healthcare providers through improved communication.
Improving Global Health Through Online CommunityJon Michaeli
Sermo working closely with medical heroes from Floating Doctors, a non-profit relief organization, brings some of the best medical expertise in the U.S. straight to patients in developing countries.
Presentation delivered at 2013 Doctors 2.0 conference in Paris focused on Sermo's iConsult real-time medicine mobile app. Features a prominent medical relief organization and how they use iConsult to help improve patient outcomes and save lives in developing countries.
The document summarizes changes made in Phase 1 of a re-branding and user experience release for WorldMate. Key changes include a new logo, website design, improved messaging on core services, streamlined workflows, updated mobile apps with a new home screen and interface, and enhanced communications and marketing materials across websites, newsletters, and emails. Screenshots demonstrate overhauls to the website, download pages, mobile apps, and other areas for a more consistent, clear, and modern experience.
4. 4
PATIENT-CENTRIC PERSONALIZED MEDICATION MANAGEMENT PLATFORM
ADDRESSING ALL MAJOR CAUSES OF NON-ADHERENCE:
Source: Cramer JA, Spilker B, eds. Patient compliance in medical practice and clinical trials. New York: Raven Press,
1991:387-92
Forgetfulness (30%)
Decision to omit doses (11%)
Emotional distress /
Lack of support (7%)
Lack of information /
Information overload (9%)
Low engagement /
Other reasons (27%)
Other priorities /
Medication costs (16%)
WHAT IS MEDISAFE?
5. Quality of Care
5
146M
Prescribed daily meds
700,000
Over/under dose
emergencies
Non-adherence
related deaths
$187B
Lost sales to pharma(cies)
$300B
Related to non-
adherence
Lost RevenuesHealthcare Costs
Sources: CVS research, 2012; CDC research, 2012; Congress report regarding non-adherence, 2012; CapGemini/HealthPrize research 2012
4 minEvery
Statistics are yearly figures (U.S)
WHAT WE’RE UP AGAINST
6. PharmaProvider / Payer / Employer
Pharmacy
Rx and Treatment
Rx Transfers / Refills
Targeted Education
AnalyticsE-Prescription, Pt. History
Pop Health, Cost Savings
Med List, Rx Coverage
Adherence Data & Biometrics
UP TO THE CHALLENGE
Doctor / Care TeamPatient / Caregiver
6
6
7. Dr. Appointments
Social Support
Patient Education - Multimedia
Telemedicine
Intrinsic Reward System
Supportive Content
Positive Reinforcement
Financial Assistance
DEMO / DATA DRIVEN FEED
11. 11
TOP 20 THERAPEUTIC AREAS
12%
4%
3%
0% 5% 10% 15% 20% 25%
Depression / Anxiety
Hypertension
Vitamin
Pain
Diabetes
Antibiotic
Seizures
High Cholesterol
Acid reduction
Hypothyroidism
Anticoagulants
Allergy
Other mental disorders
Asthma
Contraceptive
ADHD
Cancer
Epilepsy
Insomnia
Anti Inflammatory
12. 12
CLINICAL SIGNIFICANCE
Independent
comparative
study of 100
medication
management
apps.
Internal blood
pressure study of
Stage 1 and 2
hypertension
patients after
tracking their BP in
Medisafe.
Retrospective
study using RX fill
data to assess
adherence vs.
control in
hyperlipidemia,
hypertension and
diabetes.
Randomized
Control Trial with
Partners Healthcare
and Evidation Health.
Result:
Medisafe
ranked #1
Result:
19.3mmHg systolic
decline in 30 days
Result:
+8 - 20% adherence
for 3 – 6 months
Result:
Due Q4 2016
13. 13
• Safeguards
• HIPAA compliant
• Bank level security (ISO 27001)
• Medication pre-population
• Import via medical record for ~60% of
covered lives
• Streamlined UI / reduce friction
• Enhanced personalization
• Medication reconciliation
BEYOND THE PATIENT – PHASE 1
14. 14
BEYOND THE PATIENT – PHASE 2
36%
36%
35%
34%
30%
57%
47%
48%
51%
41%
0% 10% 20% 30% 40% 50% 60%
Has empathetic medical and admin staff
Scheduling appts is quick and easy
Communicates test results in timely manner
Takes time to understand my opinions and needs
Allows me to see the doctor I want, when I want
% of consumer who believe providers are dlivering % of providers who believe they're delivering
Source: Patient Experience” it’s Time to Rethink the Consumer Healthcare Journey, GE Healthcare Camden Group, March 2016
15. 15
Despite studies and a bevy of evidence from other investigators
in the field, I still get routinely reminded, when I am out
presenting on connected health, that “physicians don’t want
this data.” This is a resounding theme that ranks right up there
with concerns about liability and reimbursement.
Dr. Joe Kvedar, MD - Center for Connected Health, Partners Healthcare
Feb 25, 2016
BEYOND THE PATIENT – PHASE 2
Source: MedCity News, Feb 25, 2016
16. 16
BEYOND THE PATIENT – PHASE 2
48%
of non-health app users would use them
if recommended by doctors
Source: Technology Advice, 2014
18. 18
How do you monitor patient adherence?
Don’t monitor (21%)
Monitors via email/phone (21%)
Monitors via refills (40%) Patient self-reports (18%)
BEYOND THE PATIENT – PHASE 2
19. 21%
17%
15%22%
25%
Email
Mobile app
Patient portal
Journal
Memory / Office call / Other
19
Patients: How do you want to
share your data?
BEYOND THE PATIENT – PHASE 2
35%
65%
EMR only
Outside the EMR (email/mobile/fax)
Doctors: How do you want to
receive the data?
20. 20
Who is the first to ask about your meds?
Doctor (18%)
PA (18%)
Receptionist (5%)
Nurse/ NP (59%)
BEYOND THE PATIENT – PHASE 2
27. 27
Capital Raised To Date $7 Million
Last Funding Series A, $6 Million, Jan. 2015
Timeframe Until Next Raise 6 Months
Notable Investors:
INVESTORS
28. 28THIS DOCUMENT IS PROPRIETARY AND CONFIDENTIAL.
DAYS OF USE BY CONDITION TYPE
0 20 40 60 80 100
Acute
Hybrid
Chronic
29. In the US, medication nonadherence costs more than $100 billion annually.
Medication adherence applications (apps) are a new resource to help patients
manage their medication regimens and potentially improve adherence.
However, there are hundreds of medication adherence apps making it difficult
for patients and providers to identify quality apps. In 2012, an initial study
found 160 medication adherence apps available to consumers.
• The medication adherence app market has more than doubled in the past
two years and continues to offer apps with high variability in terms of app
quality
• No app possessed all desirable author-identified features; however, several
apps were highly rated across all four domains
• Sharing this information with healthcare providers and consumers could
enable them to find a quality app that may improve their medication
adherence
• 461 medication adherence apps were initially identified across the three marketplaces
• 367 apps were available for evaluation after removing Lite/Trial versions and apps that were specific to a single medication or disease
state
• The mean initial score based on the product description was 26.7 and ranged from 23-47 (max of 68)
• Of the 100 apps eligible for testing, 19 were excluded because they failed to produce medication reminders or could not be installed by
at least one author, which included all of the Blackberry apps, leaving 81 apps for testing
• The mean user-tested score was 27 and ranged from 13-50 (max of 68)
• Compared to the initial scores, 39 (48%) user-tested scores increased, 35 (43%) user-tested scores decreased, and 7 (9%) user-
tested scores were unchanged
Navigating the Flooded Adherence App Marketplace:
Rating the Quality of Medication Adherence Apps
Catherine Renna, Rebecca Shilling, Seth Heldenbrand, PharmD, Lindsey Dayer, PharmD, BCACP, Bradley C. Martin PharmD, PhD
• Online marketplaces (iTunes, Google Play, and Blackberry App World) were
searched for medication adherence apps during June of 2014
• Inclusion criteria: English language apps capable of generating medication
reminders
• Apps limited to a single disease state or medication were excluded
• 28 author-identified desirable app features were divided into four domains
and assessed from developer descriptions
• Each feature was assigned a score based on their importance in their
respective domain (1-modest; 2-moderate; 3-high)
• Apps with Lite/Trial versions were treated as one product
• The 100 highest scoring apps were eligible for testing and were evaluated
by two authors against developer claims
• Each app was evaluated over a four day period using a standardized six
drug regimen: vitamin E once daily, diltiazem twice daily, simvastatin once
daily at bedtime, azithromycin once daily for three days, prednisone three
day taper, and alendronate once weekly
• Apps were then re-ranked based on user-tested score
CONCLUSIONS
• Development of a searchable adherence app website in order to alleviate the
frustrations of identifying quality apps in the online marketplaces
• App effectiveness could be diminished if designed without health literacy in
mind; therefore, the addition of a health literacy domain could help in
identifying apps with the highest patient usability
• To assess the smartphone medication adherence app market by evaluating
available apps based on descriptions in the marketplace and testing the
performance of the highest-scoring apps against developer claims
• Dayer L, Heldenbrand S, et al. Smartphone medication adherence apps:
potential benefits to patients and providers. J Am Pharm Assoc. 2013; 53(
2): 172– 81
RESULTSBACKGROUND
OBJECTIVES
METHODS
FUTURE DIRECTIONS
REFERENCE
#1 OF 100 APPS REVIEWED
29
31. 31
• Difference between test and control is significant at the 95% level
Patient Cohort Timeframe Test Control Absolute Lift Relative Lift
Hyperlipidemia (n=150) 6 Months 65.3% 54.7% +10.7%* +19.5%
Hypertension (n=406) 6 Months 69.7% 64.3% +5.4%* +8.4%
Diabetes (n=143) 3 Months 84.6% 76.9% +7.7%* +10.0%
IMS RETROSPECTIVE STUDY RESULTS
32. 32
Change in Systolic BP for Medisafe Stage 1 and Stage 2 Hypertensives
Avg. Improvement of 19.3 mmHg in 30 days, persists for at least 60 days
HYPERTENSION STUDY RESULTS
33. 33
56% from Stage 1 reduced their risk category
86% from Stage 2 reduced their risk category
Normal
Pre-
Stage 1
Stage 2
HYPERTENSION STUDY RESULTS
35. 35
Category Leaders Traction Advantages Disadvantages
Reminder Apps Varies Address most
prevalent factor
Commoditized
Pharma(cy) Apps Huge customer base Deep pockets, direct tie
in to core business
Fragments the market
Med / Health Mgmt
Platforms
Some early market
traction (000,000)
Well funded Unfocused, relying on
extrinsic rewards
Health Ed / News Leaders in web traffic Audience of consumers
and providers
DNA is in media and
content, not tech
Pillboxes, Sorting Limited in consumer /
retail
Organization, reporting Low scalability, Limited
interactivity
Market Leader (med mgmt)
Addresses all major causes
Agnostic 3rd party
Patient centric
Caregiver / care coordination
Adherence focus
Medisafe Differentiation
COMPETITION
THIS DOCUMENT IS PROPRIETARY AND CONFIDENTIAL.